What is the Org number of Global Pharma Group AS?

Global Pharma Group AS is registered with Brønnøysundsregistrene under Org 928006123.

What is the revenue of Global Pharma Group AS?

Global Pharma Group AS reported revenue of 8,7 mill. kr in 2024.

Global Pharma Group AS employs 5 people as of the latest annual report.

Thomas Kristoffer Storvestre is the CEO of Global Pharma Group AS, in role since 2024.

Svein Erik Nicolaysen chairs the board of Global Pharma Group AS, in role since 2024.

Global Pharma Group AS's registered address is Bøveien 510, 8470 Bø I Vesterålen.

ASActive

Org 928006123Bøveien 510, 8470 Bø I VesterålenActivities of call centres· NACE 8220Est. 2021 · 4 years old5 employees

Actively employed in the business

Name	Role	Member since
Current (2)
TK Thomas Kristoffer Storvestre Chief Executive Officer	Chief Executive Officer	2024
RA Rikard Arne Storvestre Deputy Member	Deputy Member	2024

Former (3)


SE Svein Erik Nicolaysen Contact Person	Contact Person	2021 – 2021
HR Henrik Rødsand Chief Executive Officer	Chief Executive Officer	2021 – 2024
HH Henrik Hallstein Rødsand Chief Executive Officer	Chief Executive Officer

Non-executive oversight

Name	Role	Member since
Current (3)
SE Svein Erik Nicolaysen Chairman	Chairman	2024
PE Per Egil Sørensen Board of Directors	Board of Directors	2024
UI Unn Irene Raknestangen Kjenslie Board of Directors	Board of Directors	2026

Former (4)


TA Terje Andre Skulbru Board of Directors	Board of Directors	2024 – 2024
HR Henrik Rødsand Board of Directors	Board of Directors	2024 – 2024
HH Henrik Hallstein Rødsand

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Storvestreinvest As	Company	11.11%	11.11%	2025
Henrik Rødsand	Individual	7.27%	7.27%	2025
Silan Invest As	Company	7.02%	7.02%	2025
Ålgård Offset Finans As	Company	4.68%	4.68%	2025
Nobelsystem Scandinavia As	Company	4.62%	4.62%	2025
Per Egil Sørensen Holding As	Company	3.41%	3.41%	2025
Nettrakett As	Company	2.93%	2.93%	2025
Xpandir Scandinavia As	Company	1.77%	1.77%	2025
Seafood Holding As	Company	1.46%	1.46%	2025
Storvestre Solutions As	Company	1.45%	1.45%	2025
Lena Elisabeth Meyer Krogh	Individual	1.37%	1.37%	2025
Sayl As	Company	1.35%	1.35%	2025
Chima As	Company	1.32%	1.32%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.